Hua Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Hua Qu has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Cong-Yi Wang
Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, Translational Research of Diabetes Key Laboratory of Chongqing, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China
16 shared publications Hang Wang
Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
15 shared publications- Yi Zheng
Division of Experimental Hematology and Cancer Biology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati , Cincinnati, Ohio
14 shared publications - Huacong Deng
Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
12 shared publications Huili Wei
Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
11 shared publicationsLinlin Zhang
Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, Translational Research of Diabetes Key Laboratory of Chongqing, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China
10 shared publications
Latest Publications
- 7 August 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 313, 119098
Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis
- 7 August 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 313, 119098
Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis
- Open Access
- 7 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (32)
Renoprotective effects of tubular glucagon receptor activation mediated by V-ATPase
Recent clinical trials have shown that dual GLP-1R/GCGR agonists, including mazdutide and cotadutide, provide kidney benefits in patients with type 2 diabetes and CKD, suggesting a potential contribution of GCGR activation to these renal effects. However, whether GCGR directly confers renoprotection and the underlying mechanisms remain unclear. Here, using tubule-specific GCGR loss- and gain-of-function mouse models and human kidney samples, we show that tubular GCGR signaling exerts an important renoprotective role in DKD. Tubular GCGR expression is reduced in humans and mice with DKD and correlates with worse kidney function and increased renal injury. Genetic ablation of tubular GCGR markedly exacerbates DKD and induces pronounced phospholipid accumulation within enlarged lysosomes. Mechanistically, GCGR loss disrupts its association with the V-ATPase V1A subunit ATP6V1A, compromises V1-V0 assembly, and thereby impairs lysosomal acidification. This defect leads to impaired phospholipid hydrolysis and protease maturation, blockade of autophagic flux, and ultimately tubular cell injury. In vivo, ATP6V1A overexpression markedly reverses GCGR deficiency-induced lysosomal dysfunction and DKD progression. Consistently, re-expression of tubular GCGR via AAV9 restores lysosomal function, reduces phospholipid accumulation, and mitigates renal injury in DKD. Together, these findings provide genetic evidence for the renoprotective role of tubular GCGR in DKD, delineate a kidney-intrinsic GCGR-ATP6V1A-lysosome axis that protects tubular integrity, and extend prior GCGR-in-kidney observations into a more concrete GCGR-lysosome mechanism.
- 7 August 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (32)
Open AccessRenoprotective effects of tubular glucagon receptor activation mediated by V-ATPase
Recent clinical trials have shown that dual GLP-1R/GCGR agonists, including mazdutide and cotadutide, provide kidney benefits in patients with type 2 diabetes and CKD, suggesting a potential contribution of GCGR activation to these renal effects. However, whether GCGR directly confers renoprotection and the underlying mechanisms remain unclear. Here, using tubule-specific GCGR loss- and gain-of-function mouse models and human kidney samples, we show that tubular GCGR signaling exerts an important renoprotective role in DKD. Tubular GCGR expression is reduced in humans and mice with DKD and correlates with worse kidney function and increased renal injury. Genetic ablation of tubular GCGR markedly exacerbates DKD and induces pronounced phospholipid accumulation within enlarged lysosomes. Mechanistically, GCGR loss disrupts its association with the V-ATPase V1A subunit ATP6V1A, compromises V1-V0 assembly, and thereby impairs lysosomal acidification. This defect leads to impaired phospholipid hydrolysis and protease maturation, blockade of autophagic flux, and ultimately tubular cell injury. In vivo, ATP6V1A overexpression markedly reverses GCGR deficiency-induced lysosomal dysfunction and DKD progression. Consistently, re-expression of tubular GCGR via AAV9 restores lysosomal function, reduces phospholipid accumulation, and mitigates renal injury in DKD. Together, these findings provide genetic evidence for the renoprotective role of tubular GCGR in DKD, delineate a kidney-intrinsic GCGR-ATP6V1A-lysosome axis that protects tubular integrity, and extend prior GCGR-in-kidney observations into a more concrete GCGR-lysosome mechanism.
- Open Access
- 12 May 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2671451
Risk spectrum of admission HbA1c levels and acute pancreatitis severity: a real-world study revealing younger high-risk populations and nonlinear associations
Acute pancreatitis (AP) is clinically heterogeneous, and early identification of patients at risk for severe progression remains challenging. Glycated hemoglobin (HbA1c) reflects long-term glycemic exposure, but its prognostic relevance in AP is unclear. This study evaluated the association of admission HbA1c with AP severity and complications. We conducted a retrospective study of 324 patients hospitalized with AP at a single tertiary center. Patients were categorized into quartiles by admission HbA1c. Multivariable logistic regression assessed associations between HbA1c quartiles and severe AP or complications. Restricted cubic spline analyses explored nonlinear relationships and potential inflection points. Prespecified subgroup analyses tested robustness. Higher HbA1c levels were associated with less favorable metabolic profiles and stronger inflammatory responses at presentation. Excess risk was mainly concentrated in the highest HbA1c quartile, which showed the clearest association with severe AP and pancreatitis-related complications. Restricted cubic spline analysis demonstrated a significant nonlinear association between HbA1c and severe AP, with a potential inflection point around 6.25%, above which risk increased more markedly. A similar pattern was observed for pancreatitis-related complications. These associations were generally consistent across prespecified subgroups. However, exploratory models based on baseline admission variables, including HbA1c, showed limited discrimination, with an AUC of 0.573 for severe AP and 0.665 for complications. HbA1c may serve as an adjunct marker of metabolic vulnerability rather than a strong standalone predictor. The spline-derived inflection point should be considered exploratory and requires external validation.
- 12 May 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2671451
Open AccessRisk spectrum of admission HbA1c levels and acute pancreatitis severity: a real-world study revealing younger high-risk populations and nonlinear associations
Acute pancreatitis (AP) is clinically heterogeneous, and early identification of patients at risk for severe progression remains challenging. Glycated hemoglobin (HbA1c) reflects long-term glycemic exposure, but its prognostic relevance in AP is unclear. This study evaluated the association of admission HbA1c with AP severity and complications. We conducted a retrospective study of 324 patients hospitalized with AP at a single tertiary center. Patients were categorized into quartiles by admission HbA1c. Multivariable logistic regression assessed associations between HbA1c quartiles and severe AP or complications. Restricted cubic spline analyses explored nonlinear relationships and potential inflection points. Prespecified subgroup analyses tested robustness. Higher HbA1c levels were associated with less favorable metabolic profiles and stronger inflammatory responses at presentation. Excess risk was mainly concentrated in the highest HbA1c quartile, which showed the clearest association with severe AP and pancreatitis-related complications. Restricted cubic spline analysis demonstrated a significant nonlinear association between HbA1c and severe AP, with a potential inflection point around 6.25%, above which risk increased more markedly. A similar pattern was observed for pancreatitis-related complications. These associations were generally consistent across prespecified subgroups. However, exploratory models based on baseline admission variables, including HbA1c, showed limited discrimination, with an AUC of 0.573 for severe AP and 0.665 for complications. HbA1c may serve as an adjunct marker of metabolic vulnerability rather than a strong standalone predictor. The spline-derived inflection point should be considered exploratory and requires external validation.
- Open Access
- 14 January 2025
- Published by Bioscientifica in Endocrine Connections
- Vol. 14 (3)
Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis
Subacute thyroiditis (SAT) is an inflammatory thyroid disease characterized by neck pain, tenderness, general symptoms and thyroid dysfunction. Despite gaining new insights into the epidemiology, pathogenesis and treatment of SAT in recent years, the exact pathogenesis and determinants of its clinical progression remain unclear. Here, we profiled thyroid in situ protein alterations in fine-needle aspiration biopsy samples from SAT patients using proteomic analysis and uncovered 57 differentially abundant proteins. Gene ontology and KEGG enrichment analyses identified that these proteins were enriched in processes involving infection, inflammatory response and cell adhesion and junction, which likely contribute to the pathogenesis. Moreover, the top three high-abundance proteins (nicotinamide N-methyltransferase (NNMT), FTL and thymidine phosphorylase (TYMP)) were further validated in the plasma from a larger SAT cohort using an enzyme-linked immunosorbent assay. After adjusting for sex, Spearman correlation analysis showed that NNMT, FTL and TYMP levels were positively correlated with FT3, FT4, T3, T4, Tg and erythrocyte sedimentation rate and negatively correlated with thyroid-stimulating hormone. Furthermore, binary logistic regression analyses revealed that NNMT, FTL and TYMP were independent factors of SAT. We also conducted a receiver operating characteristic curve analysis to assess the diagnostic accuracy of NNMT, FTL and TYMP for SAT. The results revealed that each factor demonstrated an area under the curve score above 0.8. Thus, these high-abundance proteins can potentially serve as biomarkers for SAT diagnosis and outcome prediction. Our findings provide valuable insights into SAT biomarkers and shed light on the potential pathogenesis and therapeutic targets of SAT. Highlights:
- 14 January 2025
- Published by Bioscientifica in Endocrine Connections
- Vol. 14 (3)
Open AccessProteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis
Subacute thyroiditis (SAT) is an inflammatory thyroid disease characterized by neck pain, tenderness, general symptoms and thyroid dysfunction. Despite gaining new insights into the epidemiology, pathogenesis and treatment of SAT in recent years, the exact pathogenesis and determinants of its clinical progression remain unclear. Here, we profiled thyroid in situ protein alterations in fine-needle aspiration biopsy samples from SAT patients using proteomic analysis and uncovered 57 differentially abundant proteins. Gene ontology and KEGG enrichment analyses identified that these proteins were enriched in processes involving infection, inflammatory response and cell adhesion and junction, which likely contribute to the pathogenesis. Moreover, the top three high-abundance proteins (nicotinamide N-methyltransferase (NNMT), FTL and thymidine phosphorylase (TYMP)) were further validated in the plasma from a larger SAT cohort using an enzyme-linked immunosorbent assay. After adjusting for sex, Spearman correlation analysis showed that NNMT, FTL and TYMP levels were positively correlated with FT3, FT4, T3, T4, Tg and erythrocyte sedimentation rate and negatively correlated with thyroid-stimulating hormone. Furthermore, binary logistic regression analyses revealed that NNMT, FTL and TYMP were independent factors of SAT. We also conducted a receiver operating characteristic curve analysis to assess the diagnostic accuracy of NNMT, FTL and TYMP for SAT. The results revealed that each factor demonstrated an area under the curve score above 0.8. Thus, these high-abundance proteins can potentially serve as biomarkers for SAT diagnosis and outcome prediction. Our findings provide valuable insights into SAT biomarkers and shed light on the potential pathogenesis and therapeutic targets of SAT. Highlights:
- Open Access
- 19 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (39) , e2405987
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5
Non‐healing diabetic wounds and ulcer complications, with persistent cell dysfunction and obstructed cellular processes, are leading causes of disability and death in patients with diabetes. Currently, there is a lack of guideline‐recommended hypoglycemic drugs in clinical practice, likely due to limited research and unclear mechanisms. In this study, it is demonstrated that liraglutide significantly accelerates wound closure in diabetic mouse models (db/db mice and streptozotocin‐induced mice) by improving re‐epithelialization, collagen deposition, and extracellular matrix remodeling, and enhancing the proliferation, migration, and adhesion functions of keratinocytes. However, these effects of improved healing by liraglutide are abrogated in dedicator of cytokinesis 5 (Dock5) keratinocyte‐specific knockout mice. Mechanistically, liraglutide induces cellular function through stabilization of unconventional myosin 1c (Myo1c). Liraglutide directly binds to Myo1c at arginine 93, enhancing the Myo1c/Dock5 interaction by targeting Dock5 promoter and thus promoting the proliferation, migration, and adhesion of keratinocytes. Therefore, this study provides insights into liraglutide biology and suggests it may be an effective treatment for diabetic patients with wound‐healing pathologies.
- 19 August 2024
- Published by Wiley in Advanced Science
- Vol. 11 (39) , e2405987
Open AccessLiraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5
Non‐healing diabetic wounds and ulcer complications, with persistent cell dysfunction and obstructed cellular processes, are leading causes of disability and death in patients with diabetes. Currently, there is a lack of guideline‐recommended hypoglycemic drugs in clinical practice, likely due to limited research and unclear mechanisms. In this study, it is demonstrated that liraglutide significantly accelerates wound closure in diabetic mouse models (db/db mice and streptozotocin‐induced mice) by improving re‐epithelialization, collagen deposition, and extracellular matrix remodeling, and enhancing the proliferation, migration, and adhesion functions of keratinocytes. However, these effects of improved healing by liraglutide are abrogated in dedicator of cytokinesis 5 (Dock5) keratinocyte‐specific knockout mice. Mechanistically, liraglutide induces cellular function through stabilization of unconventional myosin 1c (Myo1c). Liraglutide directly binds to Myo1c at arginine 93, enhancing the Myo1c/Dock5 interaction by targeting Dock5 promoter and thus promoting the proliferation, migration, and adhesion of keratinocytes. Therefore, this study provides insights into liraglutide biology and suggests it may be an effective treatment for diabetic patients with wound‐healing pathologies.
- Open Access
- 5 June 2024
- Published by Wiley in Advanced Science
- Vol. 11 (29) , e2400819
CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Glucagon receptor (GCGR) agonism offers potentially greater effects on the mitigation of hepatic steatosis. However, its underlying mechanism is not fully understood. Here, it screened tetraspanin CD9 might medicate hepatic effects of GCGR agonist. CD9 is decreased in the fatty livers of patients and upregulated upon GCGR activation. Deficiency of CD9 in the liver exacerbated diet‐induced hepatic steatosis via complement factor D (CFD) regulated fatty acid metabolism. Specifically, CD9 modulated hepatic fatty acid synthesis and oxidation genes through regulating CFD expression via the ubiquitination‐proteasomal degradation of FLI1. In addition, CD9 influenced body weight by modulating lipogenesis and thermogenesis of adipose tissue through CFD. Moreover, CD9 reinforcement in the liver alleviated hepatic steatosis, and blockage of CD9 abolished the remission of hepatic steatosis induced by cotadutide treatment. Thus, CD9 medicates the hepatic beneficial effects of GCGR signaling, and may server as a promising therapeutic target for hepatic steatosis.
- 5 June 2024
- Published by Wiley in Advanced Science
- Vol. 11 (29) , e2400819
Open AccessCD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Glucagon receptor (GCGR) agonism offers potentially greater effects on the mitigation of hepatic steatosis. However, its underlying mechanism is not fully understood. Here, it screened tetraspanin CD9 might medicate hepatic effects of GCGR agonist. CD9 is decreased in the fatty livers of patients and upregulated upon GCGR activation. Deficiency of CD9 in the liver exacerbated diet‐induced hepatic steatosis via complement factor D (CFD) regulated fatty acid metabolism. Specifically, CD9 modulated hepatic fatty acid synthesis and oxidation genes through regulating CFD expression via the ubiquitination‐proteasomal degradation of FLI1. In addition, CD9 influenced body weight by modulating lipogenesis and thermogenesis of adipose tissue through CFD. Moreover, CD9 reinforcement in the liver alleviated hepatic steatosis, and blockage of CD9 abolished the remission of hepatic steatosis induced by cotadutide treatment. Thus, CD9 medicates the hepatic beneficial effects of GCGR signaling, and may server as a promising therapeutic target for hepatic steatosis.
- Open Access
- 1 June 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 2235-2242
Plasma Asprosin Concentrations are Associated with Progression of Diabetic Kidney Disease
Purpose: To explore the expression of asprosin in subjects with pre-DKD and DKD and to analyze its relationship with kidney injury, inflammation, and glucose and lipid metabolism. Methods: Based on urine albumin:creatinine ratio (UACr), participants were divided into DM, pre-DKD, and DKD groups. Relevant human physiological and biochemical parameters were detected in the three groups. Results: We found relatively higher levels of asprosin in both pre-DKD and DKD groups than the DM group. Moreover, data from the Nephroseq database support increased gene expression of asprosin in kidney tissue from DKD patients. Further correlation analysis revealed that the plasma asprosin level was positively correlated with age, waist circumference, waist:hip ratio, systolic blood pressure, creatinine, UACr, triglycerides, HDL-c, fasting insulin, HOMA-IR, and the inflammatory marker G3P and negatively associated with eGFR. Multiple logistical regression analysis showed that asprosin concentration was significantly associated with pre-DKD and DKD after adjusting for sex, age, BMI, WHR, and HOMA-IR, while this correlation was lost after controlling for G3P. Conclusion: Plasma asprosin is associated with kidney injury in diabetic conditions, and this association might be connected through inflammatory response. Further studies are needed to assess the role and mechanism of asprosin in DKD.
- 1 June 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 2235-2242
Open AccessPlasma Asprosin Concentrations are Associated with Progression of Diabetic Kidney Disease
Purpose: To explore the expression of asprosin in subjects with pre-DKD and DKD and to analyze its relationship with kidney injury, inflammation, and glucose and lipid metabolism. Methods: Based on urine albumin:creatinine ratio (UACr), participants were divided into DM, pre-DKD, and DKD groups. Relevant human physiological and biochemical parameters were detected in the three groups. Results: We found relatively higher levels of asprosin in both pre-DKD and DKD groups than the DM group. Moreover, data from the Nephroseq database support increased gene expression of asprosin in kidney tissue from DKD patients. Further correlation analysis revealed that the plasma asprosin level was positively correlated with age, waist circumference, waist:hip ratio, systolic blood pressure, creatinine, UACr, triglycerides, HDL-c, fasting insulin, HOMA-IR, and the inflammatory marker G3P and negatively associated with eGFR. Multiple logistical regression analysis showed that asprosin concentration was significantly associated with pre-DKD and DKD after adjusting for sex, age, BMI, WHR, and HOMA-IR, while this correlation was lost after controlling for G3P. Conclusion: Plasma asprosin is associated with kidney injury in diabetic conditions, and this association might be connected through inflammatory response. Further studies are needed to assess the role and mechanism of asprosin in DKD.
- Open Access
Mitochondrial glycerol 3-phosphate dehydrogenase deficiency exacerbates lipotoxic cardiomyopathy
- Open Access
- 31 December 2023
- Published by Wiley in Advanced Science
- Vol. 11 (11) , e2306365
Dock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid Metabolism
Podocytes are particularly sensitive to lipid accumulation, which has recently emerged as a crucial pathological process in the progression of proteinuric kidney diseases like diabetic kidney disease and focal segmental glomerulosclerosis. However, the underlying mechanism remains unclear. Here, podocytes predominantly expressed protein dedicator of cytokinesis 5 (Dock5) is screened to be critically related to podocyte lipid lipotoxicity. Its expression is reduced in both proteinuric kidney disease patients and mouse models. Podocyte‐specific deficiency of Dock5 exacerbated podocyte injury and glomeruli pathology in proteinuric kidney disease, which is mainly through modulating fatty acid uptake by the liver X receptor α (LXRα)/scavenger receptor class B (CD36) signaling pathway. Specifically, Dock5 deficiency enhanced CD36‐mediated fatty acid uptake of podocytes via upregulating LXRα in an m6A‐dependent way. Moreover, the rescue of Dock5 expression ameliorated podocyte injury and proteinuric kidney disease. Thus, the findings suggest that Dock5 deficiency is a critical contributor to podocyte lipotoxicity and may serve as a promising therapeutic target in proteinuric kidney diseases.
- 31 December 2023
- Published by Wiley in Advanced Science
- Vol. 11 (11) , e2306365
Open AccessDock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid Metabolism
Podocytes are particularly sensitive to lipid accumulation, which has recently emerged as a crucial pathological process in the progression of proteinuric kidney diseases like diabetic kidney disease and focal segmental glomerulosclerosis. However, the underlying mechanism remains unclear. Here, podocytes predominantly expressed protein dedicator of cytokinesis 5 (Dock5) is screened to be critically related to podocyte lipid lipotoxicity. Its expression is reduced in both proteinuric kidney disease patients and mouse models. Podocyte‐specific deficiency of Dock5 exacerbated podocyte injury and glomeruli pathology in proteinuric kidney disease, which is mainly through modulating fatty acid uptake by the liver X receptor α (LXRα)/scavenger receptor class B (CD36) signaling pathway. Specifically, Dock5 deficiency enhanced CD36‐mediated fatty acid uptake of podocytes via upregulating LXRα in an m6A‐dependent way. Moreover, the rescue of Dock5 expression ameliorated podocyte injury and proteinuric kidney disease. Thus, the findings suggest that Dock5 deficiency is a critical contributor to podocyte lipotoxicity and may serve as a promising therapeutic target in proteinuric kidney diseases.
- 8 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 54, 905-913
Space-Earth Integration Network Slice Mapping Based on Multi-Level Attribute Representation Model
Most of the existing network slicing methods only consider a single attribute of network nodes and ignore the overall network attributes, however, due to the different characteristics of network resources, complex node, link and topology states, a wide variety of services, etc., these algorithms may lead to a declining acceptance rate of network slicing and cannot better meet business requirements. To solve these problems, this paper provides a multi-level attribute representation model for Space-Earth Integration Network and a network slicing algorithm based on this model, called M-ARM, which considers multiple attribute characteristics of network slicing nodes. In the first stage, this method uses the resource attributes, topological attributes, location attributes and security attributes of the network slicing nodes to build the multi-level attribute representation model. In the second stage, this model is used to calculate multi-criteria decision metrics and perform node ranking, then the node mapping process in the network slice is performed based on the results of the node rank, and in the third stage, the node location deployment probability is designed and the link mapping process in the network slice is performed using the K-shortest path algorithm to avoid link congestion since frequent shortest path selection. Finally, the results of this algorithm are compared with other algorithms using simulation and simulation experiments. The experiment results show that this algorithm enhances the acceptance rate of network slicing and achieves fine-grained control of the network by the underlying infrastructure resources of the network operator matching the actual service.
- 8 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 54, 905-913
Space-Earth Integration Network Slice Mapping Based on Multi-Level Attribute Representation Model
Most of the existing network slicing methods only consider a single attribute of network nodes and ignore the overall network attributes, however, due to the different characteristics of network resources, complex node, link and topology states, a wide variety of services, etc., these algorithms may lead to a declining acceptance rate of network slicing and cannot better meet business requirements. To solve these problems, this paper provides a multi-level attribute representation model for Space-Earth Integration Network and a network slicing algorithm based on this model, called M-ARM, which considers multiple attribute characteristics of network slicing nodes. In the first stage, this method uses the resource attributes, topological attributes, location attributes and security attributes of the network slicing nodes to build the multi-level attribute representation model. In the second stage, this model is used to calculate multi-criteria decision metrics and perform node ranking, then the node mapping process in the network slice is performed based on the results of the node rank, and in the third stage, the node location deployment probability is designed and the link mapping process in the network slice is performed using the K-shortest path algorithm to avoid link congestion since frequent shortest path selection. Finally, the results of this algorithm are compared with other algorithms using simulation and simulation experiments. The experiment results show that this algorithm enhances the acceptance rate of network slicing and achieves fine-grained control of the network by the underlying infrastructure resources of the network operator matching the actual service.